All lobbying filings

Hance Scarborough

Hance Scarborough filed a Q3 report for Boehringer Ingelheim USA Corporation on October 17, 2025, reporting $20,000 in lobbying income.

Lobbying for Boehringer Ingelheim USA Corporation · Pharmaceutical Company

As filed: HANCE SCARBOROUGH for BOEHRINGER INGELHEIM USA CORPORATION.

All filings by Hance Scarborough · Everything Boehringer Ingelheim USA Corporation has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2025

July 1 - Sep 30 · Posted Oct 17, 2025

Income

$20,000

What the client paid this registrant for the period.

Client based in

Connecticut

Official filing document

Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 3

Animals

Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill

Pharmacy

Provide ongoing animal health policy monitoring, assessment, and research support. Telemedicine/telehealth legislation. Farm Bill

Agriculture

National Animal Disease Preparedness and Response Program, and the National Animal Vaccine and Veterinary Countermeasures Vaccine Bank. Farm Bill

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.